Patents Assigned to ALLEGRAN, INC.
  • Derivatives of N-urea substituted amino acids as formyl peptide receptor modulators
    Patent number: 9428549
    Abstract: The present invention relates to derivatives of N-urea substituted amino acids, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide 2 receptor.
    Type: Grant
    Filed: July 10, 2014
    Date of Patent: August 30, 2016
    Assignee: Allegran, Inc.
    Inventors: Richard L. Beard, Tien T. Duong, John E. Donello, Veena Viswanath, Michael E. Garst
  • FAT PROCESSING SYSTEM
    Publication number: 20150093362
    Abstract: Methods and devices for treating lipoaspirate for use in fat grafting procedures are provided and generally include a canister for containing lipoaspirate, a separation mechanism structured to separate both oils and other materials from cellular components of lipoaspirate contained in the canister. The separation mechanism includes filters having different filtering capacities, for example, different pore sizes.
    Type: Application
    Filed: October 2, 2013
    Publication date: April 2, 2015
    Applicant: Allegran, Inc.
    Inventors: Zachary Dominguez, Justin Schwab, Tiago Bertolote, Jason Metzner, Ethan Franklin
  • PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL
    Publication number: 20110301214
    Abstract: Disclosed herein is a pharmaceutical composition comprising (3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol and methods of using the composition to treat chronic pain.
    Type: Application
    Filed: February 12, 2010
    Publication date: December 8, 2011
    Applicant: ALLEGRAN, INC.
    Inventor: Daniel W. Gil